Non-nucleoside hepatitis B virus polymerase inhibitors identified by an in vitro polymerase elongation assay.
第一作者:
Shogo,Nakajima
第一单位:
Department of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.;Department of Applied Biological Science, Tokyo University of Science, Noda, Japan.
作者:
主题词
抗病毒药(Antiviral Agents);DNA, 病毒(DNA, Viral);药物评价, 临床前(Drug Evaluation, Preclinical);抗药性, 病毒(Drug Resistance, Viral);鸟嘌呤(Guanine);Hep G2细胞(Hep G2 Cells);乙型肝炎病毒(Hepatitis B virus);人类(Humans);半数抑制浓度(Inhibitory Concentration 50);拉米夫定(Lamivudine);蛋白质生物合成(Protein Biosynthesis);RNA指导的DNA聚合酶(RNA-Directed DNA Polymerase);重组蛋白质类(Recombinant Proteins);逆转录酶抑制剂(Reverse Transcriptase Inhibitors);二苯乙烯类(Stilbenes);病毒复制(Virus Replication)
DOI
10.1007/s00535-019-01643-0
PMID
31768802
发布时间
2021-09-16
- 浏览4
Journal of gastroenterology
441-452页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



